23 May, 15:39 - Indian

SENSEX 81721.08 (0.95)

Nifty 50 24853.15 (0.99)

Nifty Bank 55398.25 (0.83)

Nifty IT 37403.55 (0.95)

Nifty Midcap 100 56687.75 (0.64)

Nifty Next 50 67095.9 (0.57)

Nifty Pharma 21434.25 (-0.41)

Nifty Smallcap 100 17643.35 (0.80)

23 May, 15:39 - Global

NIKKEI 225 37160.47 (0.47)

HANG SENG 23601.26 (0.24)

S&P 5866.25 (-0.04)

LOGIN HERE

companylogoKMC Speciality Hospitals (India) Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 524520 | NSE Symbol : | ISIN : INE879K01018 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
07-Feb-2025 12-Feb-2025 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended 31st December 2024. In terms of provisions of Regulation 30 (read with Part A of Schedule III) and Regulations 33 and 52 of SEBI (LODR) Regulations 2015, the Board of Directors at its meeting held today,12th February 2025, have inter-alia, approved the Standalone Unaudited Financial results for the Quarter and nine months ended 31st December, 2024 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 10: 30 am and concluded at 11: 35 am. (As Per BSE Announcement Dated on 12.02.2025)
07-Nov-2024 13-Nov-2024 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the Unaudited financial results of the Company for the quarter and half year ended 30th September 2024. In terms of provisions of Regulation 30 (read with Part A of Schedule III) and Regulations 33 and 52 of SEBI (LODR) Regulations 2015, the Board of Directors at its meeting held today,13th November 2024, have inter-alia, approved the Standalone Unaudited Financial results for the Quarter and half year ended 30th September, 2024 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 10:30 am and concluded at 11:15 am. With reference to the above please find enclosed the Standalone Unaudited Financial Results for the quarter and half year ended 30th September 2024, along with the limited review report of the Auditors as approved by the Board of Directors at their meeting held today 13th November 2024. We hereby inform you that the Board Meeting commenced at 10: 31 am & concluded at 11: 15 am. (As Per BSE Announcement Dated on 13.11.2024)
08-Aug-2024 13-Aug-2024 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2024. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 13th August 2024 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter ended 30th June 2024. With reference to the above, please find enclosed the Standalone Unaudited Financial results for the Quarter ended 30th June, 2024 along with the Limited Review Report of the Auditors as approved by the Board of Directors at their meeting held today, 13th August, 2024. We hereby inform you that the Board Meeting commenced at 10:30 A.M concluded at 11:25 A.M. (As Per BSE Announcement Dated on 13.08.2024)
21-May-2024 29-May-2024 Accounts KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended 31st March 2024. With reference to the above, please find enclosed the Standalone Audited Financial results for the Quarter and year ended 31st March, 2024 along with the Auditors Report as approved by the Board of Directors at their meeting held today, 29th May, 2024. Pursuant to Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, declaration by the company with respect to Auditors Report with unmodified opinion is also enclosed. Read less.. (As Per BSE Announcement Dated on 29.05.2024)
05-Feb-2024 12-Feb-2024 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2023. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday 12th February 2024 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended 31st December 2023. This is to inform you that the Board of Directors at their meeting held today, the 12th February 2024 approved the Standalone Unaudited Financial Results for the Quarter and nine months ended 31st December 2023 along with the Limited Review Report of the Auditors, copy of which is enclosed. We hereby inform you that the Board meeting commenced at 12:41 pm and concluded at 13:40pm. This is to inform you that the Board of Directors at their meeting held today 12th February 2024 approved the Standalone Unaudited Financial Results for the Quarter and nine months ended 31st December 2023 along with the Limited Review Report of the Auditors, copy of which is attached. (As Per BSE Announcement Dated on 12/02/2024)
01-Nov-2023 10-Nov-2023 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2023. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 10th November 2023 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter and half year ended 30th September 2023. With reference to the above, please find enclosed the Standalone Unaudited Financial results for the Quarter and Half Year ended 30th September, 2023 along with the Limited Review Report of the Auditors as approved by the Board of Directors at their meeting held today, 10th November, 2023 We hereby inform you that the Board Meeting commenced at 12:35 PM concluded at 12:45 PM. (As Per BSE Announcement Dated on 10/11/2023)
04-Aug-2023 11-Aug-2023 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2023. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 11th August 2023 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter ended 30th June 2023. With reference to the above, please find enclosed the Standalone Unaudited Financial results for the Quarter ended 30th June, 2023 along with the Limited Review Report of the Auditors as approved by the Board of Directors at their meeting held today, 11th August, 2023. We hereby inform you that the Board Meeting commenced at 12:23 PM concluded at 12:48 PM. With reference to the above, please find the enclosed the standalone unaudited financial results for the quarter ended 30 June 2023 along with the limited review report of the auditors as approved by the Board of Directors at their meeting held today 11th August 2023. We hereby inform you that the Board meeting commenced at 12:23 p.m and concluded at 12:48 p.m Pursuant to the requirement under the Regulations 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the contact details of authorized person for the purpose of determining materiality of the event or information and for the purpose of making disclosure to stock exchanges is attached. 1. Board took note and accepted the resignation letter submitted by Dr.D.Senguttuvan (DIN:01867900) as Executive Director of the company with effect from 11th August, 2023- Annexure 1. 2. Board appointed Dr.D.Senguttuvan as Key Managerial personnel pursuant to Companies Act,2013, of the Company with effect from 11th August,2023-Annexure 2. 3. Board appointed Dr.S.Vijayabaskaran (DIN:05139565) as Non-Executive Director of the company with effect from 11th August 2023 subject to approval of shareholders of the company at the ensuing Annual General Meeting-Annexure 3, (As Per BSE Announcement Dated on 11.08.2023)
19-May-2023 29-May-2023 Accounts KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended 31st March 2023. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday 29th May 2023 inter-alia to consider and approve the Audited financial results of the Company for the quarter and financial year ended 31st March 2023. With reference to the above, please find enclosed the Standalone Audited Financial results for the Quarter and year ended 31st March, 2023 along with the Auditors Report as approved by the Board of Directors at their meeting held today, 29th May, 2023. Pursuant to Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, declaration by the company with respect to Auditors Report with unmodified opinion is also enclosed. We hereby inform you that the Board Meeting commenced at 12 : 45 pm and concluded at 14 : 00 pm. (As Per BSE Announcement dated on 29.05.2023)
06-Feb-2023 14-Feb-2023 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2022. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 14th February 2023 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended 31st December 2022. This is to inform you that the Board of Directors at their meeting held today, the 14th February, 2023 approved the Standalone Unaudited Financial Results for the Quarter and nine months ended 31st December,2022 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 12: 25 pm and concluded at 13: 00 pm (As per BSE Announcement Dated on 14/02/2023)
04-Nov-2022 11-Nov-2022 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2022. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 11th November 2022 inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2022 This is to inform you that the Board of Directors at their meeting held today, the 11th November, 2022 approved the Standalone Unaudited Financial Results for the Quarter and half year ended 30th September, 2022 along with the Limited Review Report of the Auditors, a copy of which is attached. We hereby inform you that the Board Meeting commenced at 12: 10 pm and concluded at 12:30 pm This is to inform you that the Board of Directors at their meeting held today, the 11th November, 2022 approved the Standalone Unaudited Financial results for the Quarter and half year ended 30th September, 2022 along with the Limited Review Report of the Auditors, copy of which is attached (As Per BSE Announcement dated on 11.11.2022)
05-Aug-2022 12-Aug-2022 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve the Unaudited financial results of the Company for the quarter ended 30th June 2022. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 12th August 2022 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter ended 30th June 2022. This is to inform you that the Board of Directors at their meeting held today, the 12th August, 2022 approved the Standalone Unaudited Financial results for the Quarter ended 30th June, 2022 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 12.25 P.M and concluded at 12.55 P.M (As per BSE Announcement Dated on 12/08/2022)
23-May-2022 30-May-2022 Accounts KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve the Audited financial results of the Company for the quarter and financial year ended 31st March 2022. With reference to the above, please find enclosed the Standalone Audited Financial results for the Quarter and year ended 31st March, 2022 along with the Auditors Report as approved by the Board of Directors at their meeting held today, 30th May, 2022. Pursuant to Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, declaration by the company with respect to Auditors Report with unmodified opinion is also enclosed. We hereby inform you that the Board Meeting commenced at 01 : 15 pm and concluded at 01 :55 pm. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirernents), Regulations, 2015, we wish to inform you that the Board of Directors at their meeting held today, the 30th May, 2022 have inter alia, based on the recommendation of the Nomination & Remuneration Committee and approval of the Board appointed Ms. Sushma K (Membership No: 64996) as the Company Secretary and Compliance Officer of the Company with effect from 15th June, 2022. The details as required under Regulation 30 of the Listing Regulations read with SEBI circular No.CIR/CFO/CMD/4/2015 dated September 9, 2015 are enclosed in Annexure 1. This is for your information and records. (As Per BSE Announcement Dated on 30/05/2022)
03-Feb-2022 11-Feb-2022 Quarterly Results KMC SPECIALITY HOSPITALS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended 31st December 2021. Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 11th February 2022 inter-alia to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended 31st December 2021. This is to inform you that the Board of Directors at their meeting held today, the 11th February, 2022 approved the Standalone Unaudited Financial results for the Quarter and nine months ended 31st December, 2021 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 12: 45 pm and concluded at 01:10 pm. (As Per BSE Announcement dated on 11.02.2022)
03-Nov-2021 12-Nov-2021 Quarterly Results Quarterly Results This is to inform you that the Board of Directors at their meeting held today, the 12th November, 2021 approved the Standalone Unaudited Financial results for the Quarter and half year ended 30th September, 2021 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 12: 35 pm and concluded at 12: 55 pm. (As per BSE Announcement Dated on 12/11/2021)
05-Aug-2021 13-Aug-2021 Quarterly Results Quarterly Results This is to inform you that the Board of Directors at their meeting held today, the 13th August, 2021 approved the Standalone Unaudited Financial results for the Quarter ended 30th June, 2021 along with the Limited Review Report of the Auditors, copy of which is enclosed for your records. We hereby inform you that the Board Meeting commenced at 12.30 P.M and concluded at 1.15 P.M 1. Board took note and accepted the resignation submitted by Dr S Aravindan (DIN: 05172690) as Director of the company with effect from the close of business hours on 13th August 2021- Annexure 1 2. Board appointed Dr D Senguttuvan (DIN: 01867900) as Executive Director of the Company with effect from 13th August 2021 subject to approval of shareholders of the company at the ensuing Annual General Meeting - Annexure 2 3. Board has appointed Ms Yasotha Benazir N (Membership No: 57316) as Company Secretary & Compliance Officer of the Company with effect from 13th August 2021 - Annexure 3 The details as required under Regulation 30 of the Listing Regulations read with SEBI circular No.CIR/CFO/CMD/4/2015 dated September 9,2015 are given in Annexure 1, 2 & 3 respectively. (As Per BSE Announcement dated on 13.08.2021)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +